drugset / Trial / NCT03251716
Berberine Treat Metabolic Syndrome in Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
In early clinical study investigators confirmed that berberine could prevent glucose and lipid metabolism disorder in schizophrenia, so investigators intend to verify the effect and safety of berberine in treatment for metabolic syndrome in schizophrenia.
Timeline
- Start
- 2015-01-01
- Primary completion
- 2017-10-30
- Completion
- 2017-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Berberine | Traditional medicine (herbal / TCM) | 300 mg | — |